Anti-inflammatory androstane derivatives

Details Anti-inflammatory androstane derivatives Anti-inflammatory androstane derivatives

2008-07-29

2008-07-29

Badio, Barbara P (Department: 1612)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S175000, C540S002000, C540S114000, C540S115000

Reexamination Certificate

active

07405206

ABSTRACT:
There are provided compounds of formula (I)whereinR1represents O, S or NH;R2represents —C(═O)-aryl or —C(═O)-heteroaryl;R3represents hydrogen, methyl (which may be in either the α or β configuration) or methylene;R4and R5are the same or different and each represents hydrogen or halogen; andrepresents a single or a double bond;and salts and solvates thereof;process for preparing them, compositions containing them and their use in therapy.

REFERENCES:
patent: 3828080 (1974-08-01), May et al.
patent: 3856828 (1974-12-01), Phillipps et al.
patent: 6537983 (2003-03-01), Biggadike et al.
patent: 6750210 (2004-06-01), Biggadike
patent: 6759398 (2004-07-01), Biggadike
patent: 6777399 (2004-08-01), Biggadike et al.
patent: 6777400 (2004-08-01), Biggadike et al.
patent: 6787532 (2004-09-01), Biggadike et al.
patent: 6858593 (2005-02-01), Biggadike et al.
patent: 6858596 (2005-02-01), Biggadike et al.
patent: 6878698 (2005-04-01), Biggadike et al.
patent: 7101866 (2006-09-01), Biggadike et al.
patent: 7125985 (2006-10-01), Biggadike et al.
patent: 2004/0028615 (2004-02-01), Briggadike et al.
patent: 2004/0220156 (2004-11-01), Biggadike et al.
patent: 2004/0224932 (2004-11-01), Biggadike et al.
patent: 2005/0020549 (2005-01-01), Biggadike et al.
patent: 2005/0043284 (2005-02-01), Biggadike et al.
patent: 2005/0130947 (2005-06-01), Biggadike
patent: 2005/0152845 (2005-07-01), Biggadike et al.
patent: 2005/0164996 (2005-07-01), Biggadike et al.
patent: 2005/0164997 (2005-07-01), Biggadike
patent: 2005/0175545 (2005-08-01), Biggadike et al.
patent: 2006/0247219 (2006-11-01), Biggadike et al.
patent: 2007/0027128 (2007-02-01), Biggadike et al
patent: 0057401 (1982-08-01), None
patent: 9724365 (1997-07-01), None
patent: WO 97/24365 (1997-07-01), None
Isogai et al., “Binding affinities of mometasone furoate and related compounds including its metabolites for the glucocorticoid receptor of rat skin tissue,”Journal of Steroid Biochemistry and Molecular Biology44(2):141-145 (1993).
Popper et al., “Structure-activity relationship of a series of novel topical corticosteroids,”Journal of Steroid Biochemistry27(4-6):837-843 (1987).
Shapiro et al., “17 Heteroaroyl esters of corticosteroids 2. 11-beta hydroxyl series,”Journal of Medicinal Chemistry30(9): 1581-1588 (1987).
Isogai M. et al; “Binding Affinities of Mometasone Furoate and Related Compounds Including its Metabolites for the Glucocorticoid Receptor of Rat Skin Tissue”; Journal of Steroid Biochemistry and Molecular Biology; 1993; 44, 2; 141-145; Elsevier Science Ltd.; Oxford, GB.
Popper T.L. et al; “Structure-Activity Relationship of a Series of Novel Topical Corticosteroids”; Journal of Steroid Biochemistry; 1987; 27, 4-6; 837-843; Pergamon Press PLC; GB.
Shapiro E.L. et al; “17 Heteroaroyl Esters of Corticosteroids 2. 11-Beta Hydroxy Series”; Journal of Medicinal Chemistry; 1987; 30, 9; 1581-1588; American Chemical Society; Washington, US.

Affiliated with

Also associated with

Rating

Anti-inflammatory androstane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-inflammatory androstane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory androstane derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2769713